Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Ophthalmology
Scleritis
Questions discussed in this category
What is your approach to management of ongoing scleritis in SLE despite mycophenolate?
1 Answer available
What is your approach to evaluation of underlying autoimmune disease in patients with bilateral scleromalacia?
1 Answer available
Are there any situations in which you would consider starting steroid-sparing agents at the outset for patients with scleritis without any evidence of systemic rheumatic disease?
2 Answers available
13883
11565
8466
Papers discussed in this category
Ophthalmology, 2014-10
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.
Lupus,
Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
Br J Ophthalmol, 2015 Apr 22
Ocular manifestations in systemic lupus erythematosus.
Am J Ophthalmol,
Episcleritis and scleritis: clinical features and treatment results.
Transplant Proc,
A prospective analysis of the effects of enteric-coated mycophenolate sodium and mycophenolate mofetil co-medicated with a proton pump inhibitor in kidney transplant recipients at a single institute in China.
Related Topics in Ophthalmology
Rheumatology
Inflammatory eye disorders
General Rheumatology
Uveitis
Systemic lupus erythematosus
Scleritis
Radiation Oncology
Infectious Disease
Hydroxychloroquine
Neuro-Ophthalmology